Growth factor-mediated cell-cell inspecific growth factors potentially involved in teractions are required for both testicular and gonadal cell-cell interactions are briefly reviewed. ovarian cell growth during gonadal development.
Introduction
The growth and development of a tissue requires the local production and integrated actions of specific growth factors. These growth factors mediate critical cell-cell interactions that control cell proliferation and organ development. The specific growth factors identified have increased dramatically in number and often exist in families. Growth factor families are composed of unique gene products that have similarities in structure and function but often dzfer in the manner in which gene expression is controlled. This allows for unique sites of expression and more precise developmental and hormonal regulation of growth factor production. A partial list of several of the major types of growth factors is shown in Table 1 to provide the nomenclature and major functions attributed to common growth factors.
Gonadal development also requires growth factor-mediated cell-cell interactions as a general mechanism to control cellular proliferation. Concerning the testis the majority of research and information available involves pubertal development and adult testis function. For the ovary the majority of information involves the process of follicular development and adult ovarian function. These will be the primary stages of development discussed in the current review; however, many of these same cell-cell interactions and growth factors will also likely be important for other stages of gonadal development. Research has also primarily been focused on the identification of the sites of production and actions of specific growth J. Anim. Sci. 1992 . 7O(Suppl. 2):30-41 factors. Therefore, the current review will emphasize the specific growth factors potentially involved in gonadal cell-cell interactions, whereas the specific functions these growth factors have during development largely remain to be elucidated.
Growth Factors in the Testis
Testis physiology requires a complex network of cell-cell interactions (Skinner, 19911 , and one class of regulatory agents involved in these interactions are growth factors (Bellve and Zheng, 19891 . The primary physiological process controlled, spermatogenesis, occurs within the seminiferous tubules, which are composed of a variety of cell types. Sertoli cells form the tubule, create the blood-testis barrier, and provide the proper structural support and microenvironment for germinal cell development. The mesenchymal [i.e., stromal) derived peritubular myoid cells surround the tubule and are separated from the epithelial Sertoli cells by a complex extracellular matrix. Leydig cells in the interstitium produce androgens necessary for testis function. Other cell types present in the interstitial tissue include macrophages, fibroblasts, and lymphatic endothelial cells. Precise growth regulation is necessary for the development of the testis and maintenance of spermatogenesis (Clermont and Perey, 1957) . During fetal development all testicular cell types proliferate. The Leydig, peritubular, and Sertoli cells continue to grow actively in the prepubertal testis. Sertoli cells terminally differentiate and cease to divide at a n early stage in pubertal development (Orth, 1982) . Peritubular-myoid cells first appear in late fetal development, and the majority of peritubular proliferation may occur during formation of tubules. Peritubular cells continue to proliferate slowly in the adult and have a defined turnover rate (Teerds et al., 1989) . Leydig cells appear in late fetal development and continue to grow and differentiate before puberty (Lording and deKretser, 1987) . Leydig cell growth is slowed but continues in the adult (Hardy et al., 1989; Teerds et al., 1989) . Compared with the somatic cells of the testis, germinal cells exhibit a delayed growth pattern. Some germinal cell development begins shortly after birth, when gonocytes mitotically divide to form spermatogonia. At the onset of puberty, germinal cells mitosis and meiosis begins, initiating "waves" of spermatogenic cell proliferation. The control of cell proliferation of these various cell types throughout testis development requires the local production and action of various growth factors. Several of the major growth factors identified to be produced and(or1 to act in the testis are summarized in Table 2 .
Insulin-Like Growth Factor
The insulin-like growth factors (IGF) derive their name from their structural similarity to insulin (Froesch et al., 1985) . Insulin-like growth factor I (previously termed somatomedin C) is considered an essential factor for cellular replication and is a progression factor for cell growth and DNA synthesis. Liver production and secretion of IGF-I accounts for the high levels of IGF-I in serum and interstitial fluid (Daughaday and Rotwein, 1989) . Insulin-like growth factor I1 is another member of this family and may act as a growth factor during fetal development.
Insulin-like growth factor I mRNA was originally identified in whole testis (Casella et al., 19871, and subsequently all the somatic cells have been shown to express and produce this factor Smith et al., 1987; Closset et al., 1989; Cailleau et al., 1990; Naville et al., 1990) . All the cell types also seem to respond to IGF. Both Sertoli and germinal cells contain receptors for IGF-I (Handelsman et al., 1985; Hansson et al., 1989; Oonk et al., 1988, 19891. Insulin-like growth factor I stimulates DNA synthesis (Borland et al., 19841, increases transferrin and lactate production in immature Sertoli cells (Skinner and Griswold, 1983; Oonk et al., 19891 , and stimulates Leydig cell steroidogenesis (Kasson and Hsueh, 1987; PerrardSapori et al., 1987) . Luteinizing hormone (LH) upregulates IGF-I receptors on Leydig cells (Lin et al., 1986;  Kasson and Hsueh, 1987; Lin et al., 1987b) . &A (+I denotes a n increase, (-1 indicates a decrease, and (?I represents an unknown function.
The presence of the blood-testis barrier prevents interstitial fluid-derived IGF-I from directly affecting sequestered germ cells. Thus, Sertoli cell production of this essential factor may allow for paracrine control of germinal cell proliferation. This is further suggested by the presence of IGF-I receptors and immunoreactivity in spermatocyctes and spermatids (Tres et al., 1986) . Local production of IGF-I binding protein may act as a mechanism to concentrate local levels of this factor (Cailleau et al., 1990) . Although IGF-I may influence cell function, speculated cell-cell interactions involving IGF-I need to be questioned because all the somatic cell types are exposed to high levels of liver-derived IGF-I present in interstitial fluid.
Another member of the IGF family, IGF-11, has also been suggested to be involved in local interactions. Both Sertoli and germinal cells contain IGF-11 receptors IO'Brien et al., 19891 , but IGF-I1 does not seem to be expressed locally (Murphy et al., 1987) . Insulin-like growth factor I1 seems to stimulate Sertoli cell differentiation, perhaps by cross-reacting with IGF-I receptors (Borland, 1984) . Neither IGF-I nor IGF-I1 has been demonstrated to act directly on germ cells, and further study is necessary to understand the physiological importance of these factors.
Transforming Growth Factor-alEpiderma1 Growth Factor
Transforming growth factor-alpha (TGF-crI is one of the structurally related peptides belonging to the epidermal growth factor (EGF) family (Derynck, 1988; Carpenter and Cohen, 1990) . Due to similar protein structure, these factors act at the same receptor to stimulate cell growth (Carpenter, 19871. Transforming growth factor-alpha is synthesized as a transmembrane precursor, which may activate EGF receptors on neighboring cells or be proteolitically cleaved to release mature peptide. Transforming growth factor-alpha seems to be produced by non-transformed cells and may play an important role as a growth regulator in normal tissues.
Epidermal growth factor has been implicated in the maintenance of spermatogenesis (Stastny and Cohen, 1972) . Removal of the salivary glands from mice resulted in a 50% reduction of mature sperm, whereas EGF replacement returned spermatogenesis to normal levels (Tsutsumi et al., 19861. Circulating concentrations of EGF, however, are considered too low to mediate endocrine action (Carpenter and Zendegui, 1986) . Epidermal growth factor does not seem to be expressed in the testis (Skinner et al., 19891 , and EGF actions may be mediated by a locally produced EGF-like factor that blocks EGF from binding to its receptor (Holmes et al., 1986) . Transforming growth factoralpha is an EGF-like factor that may mediate these effects, and both peritubular cells and Sertoli cells, but not germinal cells, express the gene for TGF-a and produce this factor . Transforming growth factor-alpha also has been immunohistochemically detected in Leydig cells (Teerds et al., 1990) . Leydig cell production of TGFa has not been demonstrated, and this observation may be due to membrane-bound TGF-a precursor or endocytosis of paracrine-derived TGF-a. Scatchard analysis indicates that high-affinity EGF receptors are present on peritubular cells (Skinner et al., 19891. Transforming growth factor-alpha stimulates peritubular cell DNA synthesis and cell division (Skinner et al., 19891. Both peritubular and Sertoli cell production of TGF-a may contribute to peritubular cell growth. At present it is unclear whether Sertoli or germinal cells contain receptors for EGF. Scatchard analysis and histochemistry do not indicate the presence of receptors on differentiated Sertoli cells Stubbs et al., 19901. However, another report presents immunological evidence that Sertoli cells may contain EGF receptors (Suarez-Quian et al., 1989) . Further examination using molecular probes for the receptor are necessary. Recent literature suggests that EGF may alter Sertoli cell function, including stimulation of lactate and inhibin production (Mallea et al., 1986; Welsh and Hsueh, 1982) . Due to potential peritubular-Sertoli interactions, analysis of Sertoli cell function requires pure preparations of Sertoli cells. Some actions of TGF-a/EGF may be mediated indirectly by peritubular cell production of other factors. Leydig cells contain EGF receptors but do not proliferate in response to EGF (Ascoli, 1981) . Epidermal growth factor/TGF-a inhibits LH-induced steroidogenesis and decreases LH receptor binding to Leydig cells (Welsh and Hsueh, 1982) . Sertoli and peritubular cell production of TGF-a may regulate interstitial cell growth during development. The role of TGF-a in Sertoli cell-germ cell interactions is also not clear. Developing spermatogonia might respond to TGF-a; this could provide an appropriate mechanism for Sertoli cells to influence spermatogonial growth. Two models using TGF-a transgenic mice, which overexpress TGF-a in the testis, show no abnormal features in this tissue (Jhappan et al., 1990; Matsui et al., 1990) .
Transforming Growth Fac t0r-P
Transforming growth factor-beta (TGF-6) is a multifunctional regulatory molecule that can stimulate or inhibit aspects of cellular growth and differentiation (Roberts and Sporn, 1988) . Transforming growth factor-beta acts as a growth inhibitor by inhibiting the actions of growth factors such as EGF/TGF-a. It can also promote cellular differentiation, extracellular matrix production, and chemotaxis. Different subtypes of TGF-P are produced as latent secreted precursors. Most cell types contain receptors for this ubiquitous factor.
Transforming growth factor-beta may also act as a multifunctional agent in the seminiferous tubule. Growth inhibitors may be necessary to prevent spermatogonial growth before puberty and to terminate growth of the maturing Sertoli cell. Studies suggest that TGF-P is produced by Sertoli cells and may be modulated by gonadotrophins (Skinner and Moses, 1989 ; B. P. Mullaney and M. K. Skinner, unpublished results). Interestingly, the testis seems to be one of the few tissues in which TGF-P3 is predominantly expressed (Miller et al., 1989) . Transforming growth factorbeta does not seem to affect immature Sertoli cell growth or cellular differentiation dramatically (Skinner and Moses, 1989) . However, TGF-P may be important in regulating environmental interactions necessary for spermatogenesis. Transforming growth factor-beta increases Sertoli cell plasminogen activator production, perhaps involved in tissue remodeling for germ cell development (Nargolwalla et al., 1990) . Due to the antagonistic growth regulation of TGF-a by TGF-P, the local production of TGF-P may act to limit TGF-a action in the tubule.
Peritubular cells also express and produce TGFp (Skinner and Moses, 1989) . Transforming growth factor-beta acts as a growth inhibitor for peritubular cells and blocks TGF-a-induced peritubular proliferation (B. P. Mullaney and M. K. Skinner, unpublished results). A number of observations suggest that TGF-P may be important in peritubular cell differentiation. Transforming growth factor-beta may regulate the production of extracellular matrix components by peritubular cells (Skinner and Moses, 19891 and increase production of plasminogen activator inhibitor type 1 (PAI-1) by peritubular cells. Transforming growth factorbeta induces peritubular cell contractility potentially required for sperm transport in the tubule (Ailenberg et al., 1990 ) and migration and colony formation of peritubular cells in culture (Skinner and Moses, 1989) . Chemotaxis stimulated by TGF-P may be a mechanism to recruit undifferentiated fibroblasts to the exterior of the tubule during development. Therefore, TGF-P may influence morphogenesis and structural formation of the seminiferous tubule.
Transforming growth factor-beta also may regu late Leydig cell growth and differentiation. Similar to TGF-a, TGF-P inhibits LH-induced steroidogenesis, possibly by decreasing LH receptor binding (Avallet et al., 1987; Lin et al., 1987a) . During development, the growth of maturing Leydig cells slows and may require a growth inhibitor such as TGF-P. Transforming growth factor-beta decreased DNA synthesis in a transformed Leydig cell line; however, TGF-P had little effect on Leydig growth in primary culture (Benahmed et al., 1989; Gonzalez-Manchon and Vale, 1989) . The local production of TGF-j3 in the interstitium needs to be determined to elucidate the importance of TGF-Pmediated cell-cell interactions.
Fibroblast Growth Factor
Fibroblast growth factor (FGF) can influence aspects of both cellular growth and differentiation . Aside from growth stimulation, recent studies indicate that FGF may play a critical role in angiogenesis and tissue repair. Fibroblast growth factor has many cellular targets and widespread tissue distribution and is important in many organ systems, including the testis (Gospodarowicz and Ferrara, 1989) .
Basic FGF (bFGF) has been isolated from bovine and human testis (Ueno et al., 1987; Story et al., 1988) . Sertoli cells seem to produce this factor, although localization of FGF gene expression has not been demonstrated . The angiogenic properties of FGF suggest that this factor may be involved in vascularization of this tissue during development. Fibroblast growth factor is mitogenic for immature Sertoli cells (Jaillard et al., 1987; Smith et al., 1989) . Basic FGF may also be important in tissue remodeling for spermatogenesis in its ability to stimulate Sertoli cell plasminogen activator activity (Jaillard et al., 1987) . Fibroblast growth factor is reported to both stimulate and inhibit Leydig steroidogenesis in different species (Fauser et al., 1988; Raeside et al., 1988; Sordoillet et al., 1988; Murono and Washburn, 1990 ). The action of FGF on germ cells has not been demonstrated. Further molecular studies are necessary to localize cellular expression of FGF and its receptor to determine its role in specific testicular cell-cell interactions.
Nerve Growth Factor
Nerve growth factor (NGF) is another mitogen that may mediate intercellular interactions involving growth (Yanker and Shooter, 1982) . Nerve growth factor is important for the development and maintenance of sympathetic neurones in the peripheral nervous system and cholinergic neurones in the central nervous system. The expression of NGF typically correlates with the amount of sympathetic innervation. Surprisingly, NGF is expressed at higher levels than expected in testosterone-dependent organs, including the testis.
Nerve growth factor mRNA is present in spermatocytes and early spermatids of the adult mouse (Olson et al., 1987; Ayer-LeLievre et al., 19881 , and Sertoli cells express NGF receptor (Persson et al., 19901. Hypophysectomy increases NGF receptor mRNA in whole testis, and replacement of LH, but not of follicle-stimulating hormone (FSH), returns expression to basal levels. This observation suggests that testosterone down-regulates the receptor and may be a n example of a gene that is negatively regulated by androgens. Interestingly, levels of NGF receptor may also correlate with stage VI-VI11 of the seminiferous cycle, perhaps stimulating the Sertoli cell for later steps in germ cell maturation. The function of NGF in the testis is not known and requires further study.
Interleukin-1
The interleukins (IL) are a family of cytokines produced by activated lymphocytes and macrophages. One of these factors, IL-1, may play a n important role in mediating cellular activation during inflammation and infection (Durum et al., 1985) . The p form of IL-1 is typically secreted by lymphocytes; however, IL-la is produced by nonimmune tissues. The mitogenic properties of these factors suggest that IL-1 may mediate growth regulation.
Interleukin-la-like activity was isolated from cultures of mature Sertoli cells, but it was absent from cultures of other testicular cell types (Gustafsson et al., 1985;  Khan et al., 1988) . Activity of IL-1 in conditioned media increases at puberty, coinciding with the onset of spermatogenesis (Syed et al., 1988) . Interleukin-1 is mitogenic for a variety of cell types; thus, the Sertoli cell might directly stimulate germ cell development through production of IL-1. One study indicated that intratesticular injection of IL-1 into hypophysectomized rats stimulated f3Hlthymidine incorporation in spermatogonia (Pollanen et al., 1989) . Presently, it is not known which cells contain IL-1 receptors; however, IL-1 can inhibit Leydig steroidogenesis (Calkins et al., 1988) . Another potential role for this cytokine may be to mediate immune suppression.
Additional Testicular Growth Factors
Other mitogenic factors found in the testis include seminiferous growth factor (SGF) and Sertoli cell-secreted growth factor (SCSGF). Seminiferous growth factor was the first mitogenic factor identified in the tubule (Feig et al., 1980) . This 16-kDA mitogen was isolated from Sertoli cell based on its affinity for heparin and seems to be immunologically distinct from FGF (Feig et al., 1983;  Bellve and Zheng, 1989) . Seminiferous growth factor stimulated growth in transformed TM4 Sertoli, TM3 Leydig cells, and 6-d-old mouse Sertoli cells (Bellve and Feig, 1984) . The activity of SGF has been detected in many species and is predominant during prepubertal development (Feig et al., 1980) . Another Sertoli cell-secreted growth factor, SCSGF, has also been partially purified and seems to be mitogenic for a number of cell lines (Buch et al., 1988) . Sertoli cell-secreted growth factor has some similarities to TGF-a, including its apparent molecular weight of 8 kDa and its ability to displace radiolabeled EGF from binding its receptor (Buch et al., 1988) . Neither SGF nor SCSGF has been fully characterized, and whether these factors are previously identified growth factor remains to be thoroughly investigated.
A number of additional growth factors have been shown to act on specific cell types or to be localized in interstitial fluid. The site of production and specific functions of these agents remains to be investigated. Factors such as activin have been shown to influence germ cell proliferation in vivo (Mather et al., 19901. Whether the actions of such agents are direct or indirectly mediated through alterations in the production of the growth factors previously discussed remains to be elucidated.
Growth Factors in the Ovary
Ovarian physiology requires rapid and continuous growth regulation associated with the process of folliculogenesis. Growth factor-mediated interactions between theca cells, granulosa cells, and the oocyte are required for the maintenance of ovarian function and the process of oogenesis. Granulosa cells provide the cytoarchitectural support for the developing oocyte and also help to form the follicle and antrum. Theca cells surround and form the exterior wall of the follicle. The interactions between theca cells and granulosa cells provide a n example of a mesenchymal (stromal)-epithelial cell interaction. The effects of this cellular interaction on oocyte development and the influence of the endocrine system on this cellular interaction are essential for female reproductive biology. The theca cells and granulosa cells of the pre-antral and small antral follicles must undergo an extensive proliferation and functional differentiation prior to ovulation (Hsueh et al., 1984) . In most large animals, follicle size increases from millimeters to centimeters. The primary cell expansion required is associated with the granulosa and theca cells. In addition to the cell proliferation required during follicle development, follicles of various stages of development become atretic and cell growth is arrested. Therefore, regulation of cell proliferation in the follicle will require stimulatory and inhibitory growth factors. Administration of FSH and estrogen has been shown to stimulate follicle cell proliferation in vivo (Goldenberg et al., 1972; Louvet and Vaitukaitis, 1976; Richards, 1979) . These hormones, however, have negligible effects on cell growth in vitro. These observations imply that the in vivo hormone actions are likely indirectly mediated through the local production of growth factors. The mechanisms and specific growth factors involved in the control of ovarian cell proliferations remain to be fully elucidated (Carson et al., 19891 . Several of the major growth factors identified to be produced and(or1 to act in the ovary are summarized in Table 3 .
Insulin-Like Growth Factor
Insulin-like growth factor I has been shown to be produced by granulosa cells under the control of growth hormone (Davoren and Hsueh, 19861, FSH, and estradiol (Hammond et al., 1985; Hsu and Hammond, 19871 . The gene expression of IGF-I has also been localized in granulosa cells (Hernandez et al., 1989; Oliver et al., 19891 but not in theca cells. The receptors for IGF-I have been localized to granulosa cells (Baranao and Hammond, 1084; Adashi et al., 1988a) and are affected by the actions of FSH (Adashi et al., 1986 (Adashi et al., , 1988b . Insulin-like growth factor I has been shown to stimulate granulosa cell oxytocin production (Schams et al., 19881, P450- (Adashi et al., 19861 , and LH receptor induction a d a s h i et al., 1985b1. In addition to effects on cellular function, IGF has been shown to stimulate the proliferation of bovine (Savion et al., 19811 and porcine (Baranao and Hammond, 19841 granulosa cells, but not rat granulosa cells, in vitro . Although theca cells do not seem to produce IGF-I, IGF-I1 gene expression has been localized to theca cells and not to granulosa cells (Hernandez et al., 1990bl . Theca cells also contain IGF receptors and respond to IGF through a n alteration in steroidogenesis (Hernandez et al., 19881 . Potential interactions between granulosa cells and theca cells through the local production and action of IGF have previously been suggested (Adashi et al., 1985a; Geisthovel et al., 19901. A physiological parameter to consider, however, is the high circulatory levels of liver-derived IGF-I available to both cell types. This is a n additional source of IGF-I that needs to be considered in understanding IGF-mediated cell-cell interactions. Insulin-like growth factor binding proteins have also been shown to be produced by ovarian cell types and are present in the follicle. These binding proteins can reduce the effective concentration and modulate the actions of IGF. Therefore, IGF will likely be a n important growth factor in the control of ovarian cell proliferation and function; however, the role and specific mechanisms involved remain to be fully elucidated.
Transforming Growth Factor-alEpiderma1 Growth Factor
Epidermal growth factor was not found to be produced in the ovary; however, a n EGF-like substance was found to be produced by theca cells (Skinner et al., 1987131 and was identified as TGFa (Kudlow et al., 1987; Skinner and Coffey, 19881. Granulosa cells were not found to express TGFa (Skinner and Coffey, 1988; Lobb et al., 19891 . The granulosa cell has been shown to contain the EGF receptor (Mondschein and Schomberg, 198 1; Chabot et al., 1985; Feng et al., 19861 , and EGF generally has inhibitory actions on adenylate cyclase (Dodson and Schomberg, 19871 , LH receptor activity (Mondschein and Schomberg, 1981; Knecht and Catt, 1983a; May et al., 19871 , and FSHinduced aromatase activity (Hsueh et al., 1981; May et al., 1982) . Transforming growth factoralpha has inhibitory actions similar to those of EGF on granulosa cells (Adashi et al., 19871 . Theca cells have also been shown to contain the EGF receptor (Skinner and Coffey, 1988) and influence steroidogenesis (Erickson and Case, 1983) . One of the initial observations on growth regulation in the ovary was the ability of EGF to stimulate granulosa cell proliferation (Gospodarowicz et al., 19771. Theca cell growth can also be stimulated by TGFa/EGF (Skinner and Coffey, 19881 . The actions of TGFa/EGF and the potential presence of EGF in the ovaries of various species can vary and remain to be fully elucidated.
The circulatory levels of EGF/TGFa are negligible and require local production within a specific organ. The ability of the theca cell to produce TGFa that can stimulate the growth of both granulosa and theca cells implies that TGFa may have an important role in promoting cell expansion during follicle development. This seems to be a mesenchymal/stromal-controlled growth process (Skinner and Coffey, 1989) . The ability of hormones to influence TGFa production may provide a mechanism for the endocrine regulation of ovarian follicle cell growth.
Transforming Growth Factor-P
Ovarian theca cells have been shown to express and produce TGFP (Skinner et al., 1987a1 , and in vivo immunocytochemical localization of TGFP is primarily confined to the theca (Thompson et al., 1989) . Although freshly isolated bovine granulosa cells do not seem to express TGFP (Skinner et al., 1987a1 , cultured rat granulosa cells have been shown to produce TGFP, which can be suppressed by FSH (Kim and Schomberg, 1989; Mulheron and Schomberg, 1990) . Therefore, theca cells seem to be a predominant source of ovarian TGFP, but granulosa cells also have the capacity to express TGFP. The specific types of TGFP expressed and their hormonal and developmental regulation remain to be fully elucidated (Mulheron et al., 19911. The local production of TGFP allows for subsequent actions on various ovarian cell types. Transforming growth factor-beta has been shown to stimulate a number of granulosa cell functions, including FSH-induced LH receptors Dodson and Schomberg, 19871, EGF actions (Feng et al., 19861 , FSH-induced aromatase activity (Ying et al., 1986; Hutchinson et al., 19871, IGF-I production (Mondschein et al., 19881 , and inhibin production (Zhiwen et al., 1988) . Transforming growth factor-beta also can influence theca cell function and steroidogenesis (Caubo et al., 1989; Magoffin et al., 1989; Hernandez et al., 1990a) . Oocyte maturation is also influenced by TGFP (Feng et al., 1988; Tsafrirri et al., 19891, although the direct vs indirect actions on oocytes remain to be investigated. In addition to effects on cellular differentiation, TGFP can also influence ovarian cell growth. Transforming growth factor-beta has been shown to inhibit TGFa/EGF-induced bovine and porcine granulosa cell growth (Skinner et al., 1987a; Mondschein et al., 1988) . Conflicting data were found with rat granulosa cells (Dorrington et al., 1988) . Transforming growth factor-beta can also inhibit TGFdEGF-induced theca cell growth (Roberts and Skinner, 1991) . Observations suggest that TGFP may have a n important role as a growth inhibitor in the ovary. The ability of TGFP to inhibit cell growth will allow for a more differentiated state of the cell, reflected in the generally stimulatory effects of TGFP observed on cell function. Therefore, the influence of TGFP on cell function may be indirectly mediated through the inhibition of cellular proliferation. Growth inhibition may be important to prevent premature cell growth of the pre-antral follicle, arrest cell growth during atresia, and control cell growth during follicle cell expansion.
Fibroblast Growth Factor
Basic FGF has been shown to be produced by granulosa cells  Koos and Olson, 19891 , and the angiogenic factor in the ovary and corpus luteum has been identified as FGF (Gospodarowicz et al., 1985) . Fibroblast growth factor can act on granulosa cells to alter the steroidogenic capacity of the cell (Baird and Hsueh, 1986; Adashi et al., 19881 , gonadotropin receptors (Mondschein and Schomberg, 19811 , and plasminogen activator expression (LaPolt et al., 1990) . In addition to these effects on cell function, FGF can stimulate granulosa cell proliferation (Gospodarowicz et al., 1977; Gospodarowicz and Bialecki, 19791 and may indirectly cause many of the effects observed on cell function. An additional role for FGF production in the ovary would be to act as a n angiogenic factor and promote vascularization of the developing follicle and corpus luteum.
Additional Growth Factors
Several additional types of growth factors have also been shown to act on and(or1 to be produced by ovarian cells. Platelet-derived growth factor (PDGF) acts on granulosa cells to enhance FSHinduced progesterone secretion, adenylate cyclase activity (Knecht and Catt, 1983b1 , and LH receptor induction (Knecht and Catt, 1983b; Mondschein and Schomberg, 1984) . The effects of PDGF on ovarian cell growth are uncertain; however, action as a potential competence factor for cell proliferation is a plausible activity. A factor that is structurally related to FGF has recently been identified as vascular endothelial growth factor (VEGF). This growth factor has been shown to be expressed in the ovary, in particular in luteal tissue, and is postulated to have a role in angiogenesis of the follicle (Phillips et al., 19901. Nerve growth factor has also been recently shown to be expressed in the ovary and is affected by ovarian innervation (Lara et al., 19901. Production of NGF in the ovary will likely have actions on ovarian sympathetic neurons.
Summary
Clearly, a large number of growth factors have been shown to be produced and to act in the testis and ovary. The majority of research has focused on the effects of specific growth factors on differentiated functions of gonadal cell types. Factors that promote cell growth generally have suppressive effects and attenuate hormone responsiveness. Factors that inhibit growth generally enhance and increase hormone responsiveness. In considering the function and physiology of locally produced growth factors, a distinction needs to be made between growth and differentiation. A factor that promotes cell proliferation and the cell cycle will indirectly reduce the differentiated state of the cell, whereas the inverse is true of a factor that arrests cell proliferation and inhibits the cell cycle. Although specific growth factors may have a role in the regulation of differentiated functions, the possibility that many of the actions observed may be the indirect result of effects on cell growth needs to be considered. Therefore, the physiological importance of growth factor regulation of differentiated function remains to be elucidated. The control of cell growth, however, will be a major function of the specific growth factors. The integrated actions of various factors such as transforming growth factors-a and -p could provide an efficient mechanism to regulate cell proliferation required in gonadal development. Further investigation of the developmental regulation of the expression, production, and action of individual growth factors will provide insight into the potential physiological roles for the various growth factors. Observations obtained imply that growth factors will likely be critical regulatory agents involved in gonadal cell-cell communication.
The endocrine regulation of gonadal cell growth has been well documented in vivo. The actions of gonadotropins and reproductive steroids, however, are distinct from the pharmacology of most growth factors. In addition, in vitro these hormones often have negligible effects on cell proliferation. The possibility that the actions of reproductive hormones on gonadal cell growth are indirectly mediated through alterations in the expression of locally produced growth factors needs to be seriously considered. Several current observations imply that hormones may regulate growth factor production. Further investigation of the hormonal regulation of the production and actions of growth factors will help elucidate the mechanisms involved in the endocrine regulation of gonadal development.
